oxazoles has been researched along with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Chen, W; Diehl, AM; Stimpson, SA; Yang, L; Zhao, C | 1 |
1 other study(ies) available for oxazoles and 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide
Article | Year |
---|---|
PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.
Topics: Activin Receptors, Type I; Adipocytes; Benzamides; Cell Line; Culture Media; Dioxoles; Extracellular Matrix Proteins; Gene Expression; Humans; Liver; Oxazoles; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Tyrosine | 2006 |